Uniphar PLC UPR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX 223.00
- Day Range
- GBX 223.00–225.00
- 52-Week Range
- GBX 178.00–300.00
- Bid/Ask
- GBX 220.00 / GBX 226.00
- Market Cap
- GBX 60.88 Bil
- Volume/Avg
- 38,221 / 45,755
Key Statistics
- Price/Earnings (Normalized)
- 13.38
- Price/Sales
- 0.27
- Dividend Yield (Trailing)
- 0.71%
- Dividend Yield (Forward)
- 0.71%
- Total Yield
- 0.71%
Company Profile
Uniphar PLC is a diversified healthcare service organization with activities in Ireland, the UK, and the Benelux. The business activities of the group function through the Commercial & Clinical division, which provides outsourced services, specifically sales, marketing, and multichannel account management to pharmaco-medical manufacturers, and distribution and support services to medical device manufacturers. The product Access division consists of two service offerings, being: On-Demand Access and Exclusive Access. Supply Chain & Retail division provides both pre-wholesale distribution and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and vEterinary surgeons in Ireland.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Core
- Total Number of Employees
- 3,262
- Website
- https://www.uniphar.ie
Comparables
Valuation
|
Metric
|
UPR
|
SALR
|
PRM
|
|---|---|---|---|
Price/Earnings (Normalized) | 13.38 | 20.54 | 14.93 |
Price/Book Value | 2.13 | 2.70 | 1.39 |
Price/Sales | 0.27 | 0.35 | 0.81 |
Price/Cash Flow | 10.18 | 14.13 | — |
Price/Earnings
UPR
SALR
PRM
Financial Strength
|
Metric
|
UPR
|
SALR
|
PRM
|
|---|---|---|---|
Quick Ratio | 0.54 | 0.80 | 1.22 |
Current Ratio | 0.88 | 1.30 | 2.33 |
Interest Coverage | 3.37 | 17.31 | 21.08 |
Quick Ratio
UPR
SALR
PRM
Profitability
|
Metric
|
UPR
|
SALR
|
PRM
|
|---|---|---|---|
Return on Assets (Normalized) | 3.70% | 5.20% | 5.95% |
Return on Equity (Normalized) | 14.51% | 14.02% | 9.38% |
Return on Invested Capital (Normalized) | 9.37% | 10.94% | 8.06% |
Return on Assets
UPR
SALR
PRM
Medical Distribution Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MCK
| McKesson Corp | Vgdrrbwp | Rmtmbs | $71.0 Bil | |
COR
| Cencora Inc | Gnxkfkqyr | Qcjcb | $48.0 Bil | |
CAH
| Cardinal Health Inc | Yfnfggl | Bswgkt | $25.1 Bil | |
SHTDY
| Sinopharm Group Co Ltd ADR | — | Qqdbyp | $8.6 Bil | |
SHTDF
| Sinopharm Group Co Ltd | — | Lcnqd | $8.6 Bil | |
SHPMF
| Shanghai Pharmaceuticals Holding Co Ltd Class H | — | Shfmw | $8.2 Bil | |
SHPMY
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H | — | Xtnrdy | $8.2 Bil | |
AMFPF
| Amplifon SpA Az nom Post Frazionamento | — | Dsggs | $7.6 Bil | |
MEPDF
| Medipal Holdings Corp | — | Gfmx | $3.3 Bil | |
MAHLY
| Medipal Holdings Corp ADR | — | Lngz | $3.3 Bil |